Robert E. Mosser

Array ( [id] => 8199543 [patent_doc_number] => 20120122930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => '1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents' [patent_app_type] => utility [patent_app_number] => 13/119835 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20925 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122930.pdf [firstpage_image] =>[orig_patent_app_number] => 13119835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066133 [patent_doc_number] => 20110243957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'MATERIALS AND METHODS FOR PREVENTING OR TREATING NEURODEGENERATIVE CONDITIONS ASSOCIATED WITH ABETA PEPTIDE ACCUMULATION' [patent_app_type] => utility [patent_app_number] => 13/120633 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19097 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243957.pdf [firstpage_image] =>[orig_patent_app_number] => 13120633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454211 [patent_doc_number] => 20100105632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals' [patent_app_type] => utility [patent_app_number] => 12/566449 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9761 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105632.pdf [firstpage_image] =>[orig_patent_app_number] => 12566449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8749078 [patent_doc_number] => 08414906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Additives and products including oligoesters' [patent_app_type] => utility [patent_app_number] => 12/586442 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26127 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12586442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113233 [patent_doc_number] => 20110190265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS BY INHIBITING QUORUM SENSING' [patent_app_type] => utility [patent_app_number] => 12/998129 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13360 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190265.pdf [firstpage_image] =>[orig_patent_app_number] => 12998129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167375 [patent_doc_number] => 20110195940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'Protease Inhibitors Having Enhanced Features' [patent_app_type] => utility [patent_app_number] => 13/119079 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 30739 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195940.pdf [firstpage_image] =>[orig_patent_app_number] => 13119079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421853 [patent_doc_number] => 08278341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Analogs of indole-3-carbinol and their use as agents against infection' [patent_app_type] => utility [patent_app_number] => 12/561656 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45514 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12561656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8653136 [patent_doc_number] => 08372885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Organic compounds and their uses' [patent_app_type] => utility [patent_app_number] => 12/557654 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27231 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12557654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6630026 [patent_doc_number] => 20100004311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'EXCITATORY AMINO ACID INHIBITORS FOR TREATING SENSITIVE SKINS' [patent_app_type] => utility [patent_app_number] => 12/556901 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3855 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004311.pdf [firstpage_image] =>[orig_patent_app_number] => 12556901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7560819 [patent_doc_number] => 20110274651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Noscapine and Noscapine Analogs and Their Use in treating Infectious Diseases by Tubulin Binding Inhibition' [patent_app_type] => utility [patent_app_number] => 13/061447 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 29757 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274651.pdf [firstpage_image] =>[orig_patent_app_number] => 13061447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6360030 [patent_doc_number] => 20100087466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'NOVEL SMALL MOLECULE DNAK INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/553648 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38776 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087466.pdf [firstpage_image] =>[orig_patent_app_number] => 12553648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937651 [patent_doc_number] => 20110212986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'ANTI-FLAVIVIRUS THERAPEUTIC' [patent_app_type] => utility [patent_app_number] => 13/060035 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18102 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212986.pdf [firstpage_image] =>[orig_patent_app_number] => 13060035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368513 [patent_doc_number] => 20090306072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'USE OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PROCESSES' [patent_app_type] => utility [patent_app_number] => 12/543984 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10892 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306072.pdf [firstpage_image] =>[orig_patent_app_number] => 12543984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501781 [patent_doc_number] => 20110263621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'NEW COMBINATION OF ACTIVE INGREDIENTS CONTAINING AN a1-ANTAGONIST AND A PDE 4 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/059760 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1768 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263621.pdf [firstpage_image] =>[orig_patent_app_number] => 13059760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216353 [patent_doc_number] => 08629153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Use of quinazoline derivatives for the treatment of viral diseases' [patent_app_type] => utility [patent_app_number] => 13/061753 [patent_app_country] => US [patent_app_date] => 2009-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6912 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13061753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257886 [patent_doc_number] => 20100029744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Methods for Alzheimer\'s Disease Treatment and Cognitive Enhancement' [patent_app_type] => utility [patent_app_number] => 12/538245 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10668 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029744.pdf [firstpage_image] =>[orig_patent_app_number] => 12538245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9112635 [patent_doc_number] => 08568803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals' [patent_app_type] => utility [patent_app_number] => 12/538000 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14656 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12538000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797180 [patent_doc_number] => 08436048 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-05-07 [patent_title] => 'Method of inhibiting AB-type bacterial toxins and treatment for associated diseases' [patent_app_type] => utility [patent_app_number] => 12/537543 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 17637 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12537543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421854 [patent_doc_number] => 08278342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Therapeutic compounds for blocking DNA synthesis of pox viruses' [patent_app_type] => utility [patent_app_number] => 12/537083 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 26545 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12537083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469915 [patent_doc_number] => 08299093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Small molecule inhibitors of retroviral assembly and maturation' [patent_app_type] => utility [patent_app_number] => 12/536738 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 11 [patent_no_of_words] => 10661 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12536738 [rel_patent_id] =>[rel_patent_doc_number] =>)